BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30057231)

  • 1. Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry).
    Shavelle DM; Banerjee S; Maini B; Schreiber TL; Kapasi N; O'Neill WW; Popma J; Matthews RV
    Am J Cardiol; 2018 Sep; 122(6):966-972. PubMed ID: 30057231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior long term outcome associated with native vessel versus graft vessel PCI following secondary PCI in patients with prior CABG.
    Mavroudis CA; Kotecha T; Chehab O; Hudson J; Rakhit RD
    Int J Cardiol; 2017 Feb; 228():563-569. PubMed ID: 27875735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
    Brilakis ES; O'Donnell CI; Penny W; Armstrong EJ; Tsai T; Maddox TM; Plomondon ME; Banerjee S; Rao SV; Garcia S; Nallamothu B; Shunk KA; Mavromatis K; Grunwald GK; Bhatt DL
    JACC Cardiovasc Interv; 2016 May; 9(9):884-93. PubMed ID: 27085582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Hannan EL
    Circulation; 2016 May; 133(22):2132-40. PubMed ID: 27151532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.
    Brilakis ES; Rao SV; Banerjee S; Goldman S; Shunk KA; Holmes DR; Honeycutt E; Roe MT
    JACC Cardiovasc Interv; 2011 Aug; 4(8):844-50. PubMed ID: 21851896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior Coronary Artery Bypass Graft Surgery and Outcome After Percutaneous Coronary Intervention: An Observational Study From the Pan-London Percutaneous Coronary Intervention Registry.
    Rathod KS; Beirne AM; Bogle R; Firoozi S; Lim P; Hill J; Dalby MC; Jain AK; Malik IS; Mathur A; Kalra SS; DeSilva R; Redwood S; MacCarthy PA; Wragg A; Smith EJ; Jones DA
    J Am Heart Assoc; 2020 Jun; 9(12):e014409. PubMed ID: 32475202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization.
    Meraj PM; Dixon S; Moses J; Ibrahim K; Schäfer A; Akin I; Hill J; Schreiber T; O'Neill WW
    J Interv Cardiol; 2019; 2019():9691753. PubMed ID: 31772553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
    Mack MJ; Head SJ; Holmes DR; Ståhle E; Feldman TE; Colombo A; Morice MC; Unger F; Erglis A; Stoler R; Dawkins KD; Serruys PW; Mohr FW; Kappetein AP
    JACC Cardiovasc Interv; 2013 Apr; 6(4):344-54. PubMed ID: 23523456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recanalization of Chronic Total Occlusions in Patients With Previous Coronary Bypass Surgery and Consideration of Retrograde Access via Saphenous Vein Grafts.
    Dautov R; Manh Nguyen C; Altisent O; Gibrat C; Rinfret S
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Mechanical Circulatory Support During Percutaneous Coronary Intervention in Patients Without Severely Depressed Left Ventricular Function.
    Alaswad K; Basir MB; Khandelwal A; Schreiber T; Lombardi W; O'Neill W
    Am J Cardiol; 2018 Mar; 121(6):703-708. PubMed ID: 29370923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease.
    Naito R; Miyauchi K; Konishi H; Tsuboi S; Ogita M; Dohi T; Kajimoto K; Kasai T; Tamura H; Okazaki S; Isoda K; Yamamoto T; Amano A; Daida H
    Heart Vessels; 2016 Sep; 31(9):1424-9. PubMed ID: 26412228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.
    Beerkens FJ; Singh R; Cao D; Claessen BE; Nicolas J; Sartori S; Snyder C; Camaj A; Giustino G; Power D; Razuk V; Jones D; Tavenier AH; Pivato CA; Nardin M; Chiarito M; Krishnan P; Barman N; Baber U; Sweeny J; Dangas G; Sharma SK; Mehran R; Kini A
    Catheter Cardiovasc Interv; 2021 Nov; 98(6):E785-E795. PubMed ID: 34478235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three treatment strategies for patients with triple-vessel coronary disease and left ventricular dysfunction.
    Jiang L; Xu L; Song L; Gao Z; Tian J; Sun K; Yu H; Xu B; Song L; Yuan J
    J Interv Cardiol; 2018 Jun; 31(3):310-318. PubMed ID: 29468730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.
    Cohen MG; Matthews R; Maini B; Dixon S; Vetrovec G; Wohns D; Palacios I; Popma J; Ohman EM; Schreiber T; O'Neill WW
    Am Heart J; 2015 Nov; 170(5):872-9. PubMed ID: 26542494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
    Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.